Brief: Vincerx Pharma To Implement Cost-Controls To Support Advancing Phase 1 Study Of VIP943

Vincerx Pharma

04/12/2024 11:58

Dec 4 (Reuters) - Vincerx Pharma  VINC.O :
    * VINCERX PHARMA TO IMPLEMENT COST-CONTROLS TO SUPPORT
ADVANCING
PHASE 1 STUDY OF VIP943
    * VINCERX PHARMA INC: WILL BEGIN EXPLORING STRATEGIC
ALTERNATIVES
TO COMPLEMENT ONGOING FUNDRAISING EFFORTS
    * VINCERX PHARMA INC: AS OF OCTOBER 31, 2024, COMPANY HAD
APPROXIMATELY $8.4 MILLION IN CASH, CASH EQUIVALENTS, AND
MARKETABLE SECURITIES
    * VINCERX PHARMA INC: TO STREAMLINE OPERATIONS AND FOCUS
RESOURCES, VINCERX WILL IMPLEMENT A SIGNIFICANT REDUCTION IN
FORCE OF APPROXIMATELY 55%

Source text:  ID:nGNX476253 
Further company coverage:  VINC.O 

 ((Reuters.Briefs@thomsonreuters.com;))